• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征特征中稳态模型评估-胰岛素抵抗、抗苗勒管激素与体重指数的相关性

Correlation of Homeostatic Model Assessment-Insulin Resistance, Anti-Mullerian Hormone, and BMI in the Characterization of Polycystic Ovary Syndrome.

作者信息

Bahadur Anupama, Verma Neha, Mundhra Rajlaxmi, Chawla Latika, Ajmani Megha, Sri Modalavalasa Swetha, Arora Shivaani

机构信息

Obstetrics and Gynecology, All India Institute of Medical Sciences, Rishikesh, IND.

出版信息

Cureus. 2021 Jun 30;13(6):e16047. doi: 10.7759/cureus.16047. eCollection 2021 Jun.

DOI:10.7759/cureus.16047
PMID:34336524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8321419/
Abstract

OBJECTIVE

To evaluate the correlation of homeostatic model assessment-insulin resistance (HOMA-IR), anti-Mullerian hormone (AMH), and BMI and to compare their values across the different phenotypes in polycystic ovary syndrome (PCOS) women of the reproductive age group.

STUDY DESIGN

A total of 307 PCOS-diagnosed women were included in the study and further classified in different phenotypes. BMI, HOMA-IR, and serum AMH values were noted and their association with different phenotypes was seen. The correlation of these variables was also noted.

RESULTS

Phenotype D was the most common phenotype followed by type A, type B, and type C. A total of 265 women had an AMH value of ≥4 mg/ml with the highest value in phenotype A followed by D, C, and B. HOMA-IR and BMI values did not vary significantly among different phenotypes. HOMA-IR and BMI had a statistically significant positive correlation and serum AMH was negatively correlated with HOMA-IR, but no significant correlation was seen between serum AMH and BMI. The biochemical parameters like luteinizing hormone (LH), follicle-stimulating hormone (FSH), LH: FSH ratio, and serum testosterone showed no correlation with phenotypes or any other clinical parameter.

CONCLUSION

HOMA-IR and BMI showed a statistically significant positive correlation indicating the need for lifestyle modification and weight reduction in PCOS women, which can further help in decreasing insulin resistance. A strong correlation of serum AMH levels and phenotypes shows the importance of serum AMH levels for classifying different PCOS phenotypes.

摘要

目的

评估稳态模型评估胰岛素抵抗(HOMA-IR)、抗苗勒管激素(AMH)与体重指数(BMI)之间的相关性,并比较其在育龄期多囊卵巢综合征(PCOS)女性不同表型中的值。

研究设计

本研究共纳入307例诊断为PCOS的女性,并进一步分为不同表型。记录BMI、HOMA-IR和血清AMH值,并观察它们与不同表型的关联。还记录了这些变量之间的相关性。

结果

D型是最常见的表型,其次是A型、B型和C型。共有265名女性的AMH值≥4mg/ml,其中A型最高,其次是D型、C型和B型。HOMA-IR和BMI值在不同表型之间无显著差异。HOMA-IR与BMI呈显著正相关,血清AMH与HOMA-IR呈负相关,但血清AMH与BMI之间无显著相关性。生化参数如促黄体生成素(LH)、促卵泡生成素(FSH)、LH:FSH比值和血清睾酮与表型或任何其他临床参数均无相关性。

结论

HOMA-IR与BMI呈显著正相关,表明PCOS女性需要改变生活方式并减轻体重,这有助于进一步降低胰岛素抵抗。血清AMH水平与表型的强相关性表明血清AMH水平在区分不同PCOS表型中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/e0a10a61c225/cureus-0013-00000016047-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/b7c74648e6f0/cureus-0013-00000016047-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/1bc2cd16a383/cureus-0013-00000016047-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/0920c1c0603b/cureus-0013-00000016047-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/52322300582f/cureus-0013-00000016047-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/e883f2d0fcd2/cureus-0013-00000016047-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/e0a10a61c225/cureus-0013-00000016047-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/b7c74648e6f0/cureus-0013-00000016047-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/1bc2cd16a383/cureus-0013-00000016047-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/0920c1c0603b/cureus-0013-00000016047-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/52322300582f/cureus-0013-00000016047-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/e883f2d0fcd2/cureus-0013-00000016047-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c84/8321419/e0a10a61c225/cureus-0013-00000016047-i06.jpg

相似文献

1
Correlation of Homeostatic Model Assessment-Insulin Resistance, Anti-Mullerian Hormone, and BMI in the Characterization of Polycystic Ovary Syndrome.多囊卵巢综合征特征中稳态模型评估-胰岛素抵抗、抗苗勒管激素与体重指数的相关性
Cureus. 2021 Jun 30;13(6):e16047. doi: 10.7759/cureus.16047. eCollection 2021 Jun.
2
The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study.中国多囊卵巢综合征女性胰岛素抵抗、肥胖与血清抗苗勒管激素水平的关系:一项回顾性单中心队列研究
Int J Womens Health. 2023 Feb 5;15:151-166. doi: 10.2147/IJWH.S393594. eCollection 2023.
3
Serum AMH levels and insulin resistance in women with PCOS.多囊卵巢综合征女性的血清抗苗勒管激素水平与胰岛素抵抗
Eur J Obstet Gynecol Reprod Biol. 2018 May;224:159-164. doi: 10.1016/j.ejogrb.2018.03.007. Epub 2018 Mar 22.
4
Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.抗苗勒管激素基因多态性与中国胰岛素抵抗型多囊卵巢综合征患者的雄激素水平相关。
J Assist Reprod Genet. 2016 Feb;33(2):199-205. doi: 10.1007/s10815-015-0641-9. Epub 2016 Jan 6.
5
The correlation between serum AMH and HOMA-IR among PCOS phenotypes.多囊卵巢综合征各表型中血清抗苗勒管激素与胰岛素抵抗指数之间的相关性。
BMC Res Notes. 2018 Feb 9;11(1):114. doi: 10.1186/s13104-018-3207-y.
6
[Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].[促黄体生成素与促卵泡生成素比值对多囊卵巢综合征患者抗苗勒管激素分泌及卵泡发生的影响]
Zhonghua Fu Chan Ke Za Zhi. 2010 Aug;45(8):567-70.
7
Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.中国非肥胖型多囊卵巢综合征女性主要表型中的血清抗苗勒管激素与胰岛素抵抗
Gynecol Endocrinol. 2014 Nov;30(11):836-9. doi: 10.3109/09513590.2014.943719. Epub 2014 Jul 21.
8
[Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].[抗苗勒管激素在多囊卵巢综合征主要表型中的作用]
Akush Ginekol (Sofiia). 2014;53(5):22-7.
9
[CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].[多囊卵巢综合征伴或不伴胰岛素抵抗患者中抗苗勒管激素与激素及卵巢形态特征的相关性]
Georgian Med News. 2018 Feb(Issue):34-40.
10
Anti-Müllerian Hormone Accelerates Pathological Process of Insulin Resistance in Polycystic Ovary Syndrome Patients.抗苗勒氏管激素加速多囊卵巢综合征患者胰岛素抵抗的病理进程。
Horm Metab Res. 2021 Aug;53(8):504-511. doi: 10.1055/a-1499-7718. Epub 2021 Aug 12.

引用本文的文献

1
Effects of Omega-3 Fatty Acid Supplementation on Serum Fetuin-A Levels in Patients With Coronary Artery Disease.补充ω-3脂肪酸对冠心病患者血清胎球蛋白-A水平的影响。
Food Sci Nutr. 2025 Jun 18;13(6):e70460. doi: 10.1002/fsn3.70460. eCollection 2025 Jun.
2
Evaluation of Anti-Müllerian Hormone (AMH) Serum Levels in Patients with Polycystic Ovary Syndrome (PCOS) Depending on Body Mass Index (BMI).根据体重指数(BMI)评估多囊卵巢综合征(PCOS)患者的抗苗勒管激素(AMH)血清水平。
J Clin Med. 2025 Apr 14;14(8):2677. doi: 10.3390/jcm14082677.
3
Association between anti-mullerian hormone and metabolic syndrome: insights from a prospective community-based study.

本文引用的文献

1
Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes.不同多囊卵巢综合征表型的身体成分、雄激素血清浓度与胰岛素抵抗
J Clin Med. 2020 Mar 9;9(3):732. doi: 10.3390/jcm9030732.
2
Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes - a cross-sectional study.不同多囊卵巢综合征(PCOS)表型中体质量指数(BMI)、抗缪勒管激素(AMH)和胰岛素抵抗的相关性——一项横断面研究。
Gynecol Endocrinol. 2019 Nov;35(11):970-973. doi: 10.1080/09513590.2019.1613640. Epub 2019 May 12.
3
抗缪勒管激素与代谢综合征的关系:一项基于社区的前瞻性研究的启示。
BMC Endocr Disord. 2024 Jun 27;24(1):97. doi: 10.1186/s12902-024-01627-z.
4
Neuregulin 4 in Polycystic Ovarian Syndrome (PCOS) Phenotypes: A Key Role or Standby.多囊卵巢综合征(PCOS)表型中的神经调节蛋白4:关键作用还是备用角色。
Rep Biochem Mol Biol. 2023 Oct;12(3):359-365. doi: 10.61186/rbmb.12.3.359.
5
Assessing the clinical diagnostic value of anti-Müllerian hormone in polycystic ovarian syndrome and its correlation with clinical and metabolism indicators.评估抗缪勒管激素在多囊卵巢综合征中的临床诊断价值及其与临床和代谢指标的相关性。
J Ovarian Res. 2024 Apr 10;17(1):78. doi: 10.1186/s13048-024-01405-4.
6
Metabolic Syndrome Rather Than Other Phenotypes in PCOS as a Predictive Indicator for Clinical Outcomes in IVF: Comprehensive Phenotypic Assessment across All PCOS Classifications.多囊卵巢综合征中的代谢综合征而非其他表型作为体外受精临床结局的预测指标:对所有多囊卵巢综合征分类的综合表型评估
J Clin Med. 2023 Aug 2;12(15):5073. doi: 10.3390/jcm12155073.
7
Polymorphisms of mtDNA in the D-loop region moderate the associations of BMI with HOMA-IR and HOMA-β among women with polycystic ovary syndrome: a cross-sectional study.线粒体 DNA 多态性在 D-环区调节多囊卵巢综合征妇女体重指数与 HOMA-IR 和 HOMA-β 的关联:一项横断面研究。
J Assist Reprod Genet. 2023 Aug;40(8):1983-1993. doi: 10.1007/s10815-023-02843-7. Epub 2023 Jun 26.
8
Free androgen index (FAI)'s relations with oxidative stress and insulin resistance in polycystic ovary syndrome.多囊卵巢综合征患者游离雄激素指数(FAI)与氧化应激和胰岛素抵抗的关系。
Sci Rep. 2023 Mar 29;13(1):5118. doi: 10.1038/s41598-023-31406-0.
9
Visceral Adiposity Index as an Indicator for Menstrual Disturbance, Hormonal and Metabolic Dysfunction in Polycystic Ovarian Syndrome.内脏脂肪指数作为多囊卵巢综合征月经紊乱、激素及代谢功能障碍的指标
Cureus. 2022 Sep 30;14(9):e29796. doi: 10.7759/cureus.29796. eCollection 2022 Sep.
10
Evaluation of anti-Müllerian hormone in pre-menopausal women stratified according to thyroid function, autoimmunity and age.根据甲状腺功能、自身免疫和年龄分层的绝经前女性抗苗勒管激素评估。
Thyroid Res. 2022 Aug 15;15(1):15. doi: 10.1186/s13044-022-00133-5.
Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
激素谱分析,包括抗苗勒管激素(AMH),用于多囊卵巢综合征(PCOS)的诊断和 PCOS 表型的特征描述。
Gynecol Endocrinol. 2019 Jul;35(7):595-600. doi: 10.1080/09513590.2018.1559807. Epub 2019 Jan 22.
4
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.多囊卵巢综合征评估与管理的国际循证指南推荐意见。
Hum Reprod. 2018 Sep 1;33(9):1602-1618. doi: 10.1093/humrep/dey256.
5
The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.循环鸢尾素水平与多囊卵巢综合征不同表型的相关性。
J Endocrinol Invest. 2018 Dec;41(12):1401-1407. doi: 10.1007/s40618-018-0902-4. Epub 2018 May 21.
6
Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients.多囊卵巢综合征患者胰岛素抵抗与心血管危险因素之间的关联。
Rev Bras Ginecol Obstet. 2018 Apr;40(4):188-195. doi: 10.1055/s-0038-1642634. Epub 2018 May 10.
7
Serum AMH levels and insulin resistance in women with PCOS.多囊卵巢综合征女性的血清抗苗勒管激素水平与胰岛素抵抗
Eur J Obstet Gynecol Reprod Biol. 2018 May;224:159-164. doi: 10.1016/j.ejogrb.2018.03.007. Epub 2018 Mar 22.
8
The correlation between serum AMH and HOMA-IR among PCOS phenotypes.多囊卵巢综合征各表型中血清抗苗勒管激素与胰岛素抵抗指数之间的相关性。
BMC Res Notes. 2018 Feb 9;11(1):114. doi: 10.1186/s13104-018-3207-y.
9
Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.人抗苗勒管激素(AMH)类似物在生殖医学中的潜在治疗应用。
J Assist Reprod Genet. 2017 Sep;34(9):1105-1113. doi: 10.1007/s10815-017-0977-4. Epub 2017 Jun 22.
10
Effect of obesity and its related metabolic factors on serum anti-Müllerian hormone concentrations in women with and without polycystic ovaries.肥胖及其相关代谢因素对患有和未患有多囊卵巢的女性血清抗苗勒管激素浓度的影响。
Reprod Biomed Online. 2017 Sep;35(3):325-330. doi: 10.1016/j.rbmo.2017.05.013. Epub 2017 Jun 3.